Peer-reviewed paper in 2026 shows mycelial compounds effective against respiratory diseases?
One-OffSağlık ve TıpBilim2ayManifold MarketsKYC yokDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel topluluk tahminiEvet 81.4%
Tahminciler
12
Soru türü
binary
Yöntem
Play-money forecasting platform
Kaynak türü
Tahmin
Piyasa verileri
1 saat önce güncellendi
Gecikmeli12 Kas 25 04:56 UTC31 Ara 26 23:59 UTC
Trendler
İlgili Piyasalar
Bağlam için ilgili sorular; eşdeğer sözleşmelerin karşılaştırması değildir.
Will a peer-reviewed paper analyzing UAP sensor data be published in a Nature-family journal before January 1, 2027?
Manifold MarketsDate first peer reviewed manuscript in Cell, Nature, or Science concludes SARS2 lab origin more likely than not (Set)
Manifold MarketsWill China unveil a peer reviewed surgical cure for Alzheimers by the end of 2026?
Manifold MarketsWill a graviton be directly observed in a peer-reviewed paper before 2100?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiWill the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?
Manifold MarketsKurallar
Particularly against severe / pandemic-risk disease such as CoV-2, H5N1, or so on.
- Resolves YES if one is published which shows statistically significant effects using mushroom or mycelium-derived extracts or compounds.
- Otherwise NO at end of 2026.
